Petar Podlesniy

Petar Podlesniy

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2013 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
PPPetar Podlesniy
Petar Podlesniy
JFJoana Figueiro‐Silva
Joana Figueiro‐Silva
AAAnna Antonell
Anna Antonell
RSRaquel Sánchez-Valle
Raquel Sánchez-Valle
DADaniel Alcolea
Daniel Alcolea
Ramon TrullasRamon Trullas
Ramon Trullas

1 February 2005 in The American Journal of Pathology
Verified
Journal Article
Closed access
CPCarlos E. Pedraza
Carlos E. Pedraza
PPPetar Podlesniy
Petar Podlesniy
NVNOEMI VIDAL
NOEMI VIDAL
JAJuan Carlos Arévalo
Juan Carlos Arévalo
RLRamee Lee
Ramee Lee
CECarme Espinet
Carme Espinet

1 July 2006 in The American Journal of Pathology
Verified
Journal Article
Open access
PDF file
PPPetar Podlesniy
Petar Podlesniy
AKAnton Kichev
Anton Kichev
CPCarlos Pedraza
Carlos Pedraza
JSJordi Saurat
Jordi Saurat
MEMario Encinas
Mario Encinas
CECarme Espinet
Carme Espinet
The pro form of neurotrophic growth factor (pro-NGF), purified by chromatography from human Alzheimer's disease (AD)-affected brains (ADhbi-pro-NGF), has been shown to induce apoptotic cell death in neuronal cell cultures through its interaction with the p75 neurotrophin receptor (p75NTR). In the present work, we report that ADhbi-pro-NGF stimulates processing of p75NTR with alpha- and gamma-secretases, yielding a 20-kd intracellular domain (p75(ICD)) that translocates to the nucleus. This process was accompanied by delayed apoptosis. In AD, p75(ICD) was significantly increased in human entorhinal cortex. Although human frontal cortex has been described as showing a higher pro-NGF increase in AD, the increase in the entorhinal cortex paralleled p75NTR processing in its intracellular domain. In addition, pro-NGF isolated from AD-affected brains differed functionally from pro-NGF isolated from comparably aged control brains, with pro-NGF isolated from control brains being unstable and undergoing degradation to NGF when added to cell culture. As p75(ICD) and pro-NGF are both mediators of apoptosis and are both found in increased levels in the cerebral cortex in AD, the present data have implications for understanding neuronal degeneration in AD.

8 April 2015 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JFJoana Figueiro-Silva
Joana Figueiro-Silva
AGAgnès Gruart
Agnès Gruart
KCKevin Bernard Clayton
Kevin Bernard Clayton
PPPetar Podlesniy
Petar Podlesniy
MAM. Alba Abad
M. Alba Abad
Ramon TrullasRamon Trullas
Ramon Trullas
In mature neurons, the number of synapses is determined by a neuronal activity-dependent dynamic equilibrium between positive and negative regulatory factors. We hypothesized that neuronal pentraxin (NP1), a proapoptotic protein induced by low neuronal activity, could be a negative regulator of synapse density because it is found in dystrophic neurites in Alzheimer's disease-affected brains. Here, we report that knockdown of NP1 increases the number of excitatory synapses and neuronal excitability in cultured rat cortical neurons and enhances excitatory drive and long-term potentiation in the hippocampus of behaving mice. Moreover, we found that NP1 regulates the surface expression of the Kv7.2 subunit of the Kv7 family of potassium channels that control neuronal excitability. Furthermore, pharmacological activation of Kv7 channels prevents, whereas inhibition mimics, the increase in synaptic proteins evoked by the knockdown of NP1. These results indicate that NP1 negatively regulates excitatory synapse number by modulating neuronal excitability and show that NP1 restricts excitatory synaptic plasticity.

1 January 2012 in Experimental Neurology
Verified
Journal Article
Closed access
BLBeatriz López-Hernández
Beatriz López-Hernández
IPInmaculada Posadas
Inmaculada Posadas
PPPetar Podlesniy
Petar Podlesniy
MAMaría A. Abad
María A. Abad
Ramon TrullasRamon Trullas
Ramon Trullas
VCValentín Ceña
Valentín Ceña

Verified
Journal Article
Open access
PDF file
KSKristine Salmina
Kristine Salmina
Agnieszka BojkoAgnieszka Bojko
Agnieszka Bojko
IIInna Inashkina
Inna Inashkina
KSKarolina Staniak
Karolina Staniak
MDMagdalena Dudkowska
Magdalena Dudkowska
Jekaterina ErenpreisaJekaterina Erenpreisa
Jekaterina Erenpreisa
Mitotic slippage (MS), the incomplete mitosis that results in a doubled genome in interphase, is a typical response of TP53-mutant tumors resistant to genotoxic therapy. These polyploidized cells display premature senescence and sort the damaged DNA into the cytoplasm. In this study, we explored MS in the MDA-MB-231 cell line treated with doxorubicin (DOX). We found selective release into the cytoplasm of telomere fragments enriched in telomerase reverse transcriptase (hTERT), telomere capping protein TRF2, and DNA double-strand breaks marked by γH2AX, in association with ubiquitin-binding protein SQSTM1/p62. This occurs along with the alternative lengthening of telomeres (ALT) and DNA repair by homologous recombination (HR) in the nuclear promyelocytic leukemia (PML) bodies. The cells in repeated MS cycles activate meiotic genes and display holocentric chromosomes characteristic for inverted meiosis (IM). These giant cells acquire an amoeboid phenotype and finally bud the depolyploidized progeny, restarting the mitotic cycling. We suggest the reversible conversion of the telomerase-driven telomere maintenance into ALT coupled with IM at the sub-telomere breakage sites introduced by meiotic nuclease SPO11. All three MS mechanisms converging at telomeres recapitulate the amoeba-like agamic life-cycle, decreasing the mutagenic load and enabling the recovery of recombined, reduced progeny for return into the mitotic cycle.